Mark S. Cohen > Pearl Cohen Zedek Latzer Baratz > Tel Aviv, Israel > Lawyer Profile

Pearl Cohen Zedek Latzer Baratz
Azrieli Sarona Tower, 121 Menachem Begin Road
53rd floor
Tel Aviv, 6701203
Israel
Mark S. Cohen photo

Work Department

Mark Cohen is a founder of Pearl Cohen Zedek Latzer Baratz, Senior Partner, Chair of the Life Science Practice Group, and a member of the firm’s Executive Committee.

Position

Mark’s practice focuses on patent prosecution in the pharmaceutical, chemical, biological, and medical device areas, as well as licensing and client counseling. He is well-versed in all aspects of patent prosecution, intellectual property management, strategic advice, technology assessment, and licensing matters. His work includes management of large patent portfolios, negotiating terms, drafting agreements, and counseling start-ups. He has been involved in large due diligence matters; infringement, validity and patentability opinions; licensing matters; and opposition proceedings in Europe.

Career

Mark Cohen is a Board Member of Masthercell Global Inc. a subsidiary of Orgenesis Inc. (Nasdaq: ORGS), a manufacturer, service provider and developer of advanced cell therapies. Mark Cohen was Vice Chairman of the Board, and Chairman of the Governance and Nominating Committee of Akari Therapeutics, Plc. (NASDAQ: AKTX) an emerging biopharmaceutical company that is developing anti-complement and anti-inflammatory molecules as life-transforming treatments for a wide range of severe and orphan autoimmune and inflammatory diseases.

He has published in Nature Biotechnology and various patent trade journals. He has lectured at the Practicing Law Institute (PLI) and the American Conference Institute on general patent topics, and at other venues in the US and Europe on patent issues in the biotechnology/ pharmaceutical area. Mark also served as Editor-in-Chief of the University of Baltimore Intellectual Property Law Journal.

His clients that he represents range from start-up companies to Fortune 500 companies. He represents global corporation, as well as mid-size companies; private companies, technology transfer offices of academic institutions; fundamental institutional funds; and start-up companies in the biotechnology/biopharmaceutical/immunotherapy area.

Languages

English

Education

University of Baltimore School of Law, J.D., 1993
New York University, M.Sc. Biology, 1990
Rutgers University, B.A. Biochemistry, 1989

Lawyer Rankings

Israel > Healthcare and life sciences

Pearl Cohen Zedek Latzer Baratz is well known for handling contentious and non-contentious patent matters. The group also specialises in advising clients across the spectrum of life sciences on corporate transactions and employment issues. Zeev Pearl has over two decades of experience advising clients on IP issues, including portfolio development, licensing and litigation. Mark Cohen is an expert in patent prosecution regarding pharmaceuticals, medical devices and biotech. Yael Baratz is often instructed by clients to handle cross-border M&A transactions.

Israel > Intellectual property > Intellectual property: filing/prosecution

Pearl Cohen Zedek Latzer Baratz provides a first-class service in all areas of IP, working with recognisable clients from the retail, hi-tech and pharmaceutical industries on the protection of their inventions, designs and branding. Complex prosecution is a particular specialism; the firm files petitions to cancel the allowance of a patent application by client’s competitors. Managing partner Zeev Pearl focuses on patents, primarily in the information technology, energy and pharmaceutical sectors. On the trade marks side, Dor Cohen Zedek manages the worldwide portfolios of domestic and international clients. Mark Cohen is recommended for life sciences work.

Israel > Intellectual property > Intellectual property: commercial/transactions

With offices in the US and UK, Pearl Cohen Zedek Latzer Baratz is able to advise on cross border licensing transactions (most notably in the telecoms and pharmaceutical sectors), as well as the IP elements of M&A transactions. Zeev Pearl, who is one of the firm’s founders, works with global companies on the IP aspects of their operations in Israel. Fellow founder Mark Cohen leads the life sciences group and splits his practice between Tel Aviv and New York. Yael Baratz represents the technology transfer companies of academic research institutions.